Rapidly growing left atrial myxoma: a case report

<p>Abstract</p> <p>Introduction</p> <p>Left atrial myxomas are rare benign tumors of the heart. They vary widely in size, and very little is known about their growth rate. The reported growth rates of left atrial myxomas from several published case reports appears to vary from no growth, to between 1.3 to 6.9 mm/month in diameter within patients with established myxoma who have not undergone surgery.</p> <p>Case presentation</p> <p>We present the case of a rapidly growing pedunculated left atrial myxoma in a 62-year-old asymptomatic Caucasian woman found incidentally during routine transthoracic echocardiography. Our patient was attending her annual valve clinic assessment for moderate aortic regurgitation, and her two previous consecutive transthoracic echocardiography scans performed 12 and 24 months prior to this appointment had demonstrated a clear left atrium and aortic regurgitation of moderate severity.</p> <p>Conclusions</p> <p>To the best of our knowledge, our case is the first to provide images of absence and presence of myxoma from transthoracic echocardiography scans taken a year apart, with estimated growth rate of 2.2 mm/month. Rapidly growing myxoma may be mistaken for thrombus, and may require urgent surgical excision to reduce the risk of associated complications such as thrombo-embolic events, sudden cardiac death and removal of a possibly malignant tumor. The potential for rapid growth should be considered if there is a plan to delay surgery. Furthermore, it would be pertinent to consider annual echocardiography in patients presenting with clinical features suggestive of cardiac myxoma such as constitutional symptoms, as these tumors may be rapid growing and may only become apparent on subsequent echocardiography.</p

PERFORMANCE TESTING OF 2-STROKE PETROL ENGINE ON THE PREMISE OF VARIATION IN MECHANICAL DEVICE

A two shock generator is one whichever completes its course of action in one innovation of the crankshaft or in two shocks of the generator. In many two shock weapons, the automated system is remarkably abstract by adopting the generator as an accelerate spigot intimately profit and exhaust ports discontinue sidelong of the barrel. A carburetor is that any a petrol transformer that provides conformity air-fuel mix as and when needed. The reporter has used sole circular solid two caresses developmental way. A jockey controls the turbine hurry by developing or discounting on the part of fuel by reason particle accelerator tool. The empirical culminates show that that size of the main jet gives excels rise lower assorted load and gear running condition

Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition

Following a myocardial infarction (MI), the immune system helps to repair ischaemic damage and restore tissue integrity, but excessive inflammation has been implicated in adverse cardiac remodelling and development towards heart failure (HF). Pre-clinical studies suggest that timely resolution of inflammation may help prevent HF development and progression. Therapeutic attempts to prevent excessive post-MI inflammation in patients have included pharmacological interventions ranging from broad immunosuppression to immunomodulatory approaches targeting specific cell types or factors with the aim to maintain beneficial aspects of the early post-MI immune response. These include the blockade of early initiators of inflammation including reactive oxygen species and complement, inhibition of mast cell degranulation and leucocyte infiltration, blockade of inflammatory cytokines, and inhibition of adaptive B and T-lymphocytes. Herein, we provide a systematic review on post-MI immunomodulation trials and a meta-analysis of studies targeting the inflammatory cytokine Interleukin-1. Despite an enormous effort into a significant number of clinical trials on a variety of targets, a striking heterogeneity in study population, timing and type of treatment, and highly variable endpoints limits the possibility for meaningful meta-analyses. To conclude, we highlight critical considerations for future studies including (i) the therapeutic window of opportunity, (ii) immunological effects of routine post-MI medication, (iii) stratification of the highly diverse post-MI patient population, (iv) the potential benefits of combining immunomodulatory with regenerative therapies, and at last (v) the potential side effects of immunotherapies

The Concept of Educational Achievement and its Effective Factors according to the Overseas Graduates’ Point of View: a Qualitative Study

Background & Objective : The importance of dispatching students to foreign countries to continue education is so obvious that even developed countries are not needless of that. Hence, this study was conducted to evaluate the opinion of overseas graduates, who were on a scholarship, about the meaning and concepts of educational achievement and its effective factors. Methods : In this qualitative study, 11 faculty members of Kerman University of Medical Sciences who have been graduated from foreign universities participated. They were inquired into their opinions about assessment criteria of educational achievement and its effective factors using an open interview. Results : Among the most important concepts of educational achievement regarding education quantity, attending seminars and conferences can be pointed out. The efficiency of learned materials and learning professional scientific topics are important considering education quality and learning extra topics, respectively. The interviewees also believed that personal factors including personality, family, economic affairs, having professional knowledge in the field of study, necessary skills in the language of the target university and its status especially tutors, topic and field of research were also substantial. Conclusion : Our findings suggest that concepts of academic achievement are vast and one cannot be considered successful assessing only one or some criteria. Hence, duration of study, the amount of scientific products and their quality, the amount of scientific connections and the application of learned topics by the learner are to be noted. Keywords: Educational achievement, Overseas student, Medical sciences, Overseas graduate

Central and peripheral quadriceps fatigue in congestive heart failure

AbstractAimsThe clinical syndrome of heart failure includes exercise limitation that is not directly linked to measures of cardiac function. Quadriceps fatigability may be an important component of this and this may arise from peripheral or central factors.Methods and resultsWe studied 10 men with CHF and 10 healthy age-matched controls. Compared with a rest condition, 10min after incremental maximal cycle exercise, twitch quadriceps force in response to supramaximal magnetic femoral nerve stimulation fell in both groups (CHF 14.1%±18.1%, p=0.037; Control: 20.8±11.0%, p<0.001; no significant difference between groups). There was no significant change in quadriceps maximum voluntary contraction voluntary force. The difference in the motor evoked potential (MEP) response to transcranial magnetic stimulation of the motor cortex between rest and exercise conditions at 10min, normalised to the peripheral action potential, also fell significantly in both groups (CHF: 27.3±38.7%, p=0.037; Control: 41.1±47.7%, p=0.024). However, the fall in MEP was sustained for a longer period in controls than in patients (p=0.048).ConclusionsThe quadriceps is more susceptible to fatigue, with a similar fall in TwQ occurring in CHF patients at lower levels of exercise. This is associated with no change in voluntary activation but a lesser degree of depression of quadriceps motor evoked potential

Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.

Following a myocardial infarction (MI), the immune system helps to repair ischaemic damage and restore tissue integrity, but excessive inflammation has been implicated in adverse cardiac remodelling and development towards heart failure (HF). Pre-clinical studies suggest that timely resolution of inflammation may help prevent HF development and progression. Therapeutic attempts to prevent excessive post-MI inflammation in patients have included pharmacological interventions ranging from broad immunosuppression to immunomodulatory approaches targeting specific cell types or factors with the aim to maintain beneficial aspects of the early post-MI immune response. These include the blockade of early initiators of inflammation including reactive oxygen species and complement, inhibition of mast cell degranulation and leucocyte infiltration, blockade of inflammatory cytokines, and inhibition of adaptive B and T-lymphocytes. Herein, we provide a systematic review on post-MI immunomodulation trials and a meta-analysis of studies targeting the inflammatory cytokine Interleukin-1. Despite an enormous effort into a significant number of clinical trials on a variety of targets, a striking heterogeneity in study population, timing and type of treatment, and highly variable endpoints limits the possibility for meaningful meta-analyses. To conclude, we highlight critical considerations for future studies including (i) the therapeutic window of opportunity, (ii) immunological effects of routine post-MI medication, (iii) stratification of the highly diverse post-MI patient population, (iv) the potential benefits of combining immunomodulatory with regenerative therapies, and at last (v) the potential side effects of immunotherapies

Comparison of genetic diversity of leptin gene between wild goat and domestic goat breeds in Iran

Leptin is a polypeptide which is mostly secreted by the white adipose tissue and a little by gastrointestinal tract and placenta, plays an important role for controlling body weight, feed intake, immunity, milk production, and reproduction. The aim of this study was to investigate the exon 2 of the leptin gene polymorphism in Iranian wild and domestic goats using PCRRFLP. Blood samples were collected from 14 wild and domestic goat breeds including (Cashmere Abadeh, Torki-Ghahghaei, Naeini, Robati, Nadoushani, Adani, Shahrbabaki, Birjandi, China goat, Sannen, Pakistani, Raeini cashmere, Najdi, and Wild goat) and then genomic DNA was extracted. A 152 bp fragment from exon 2 of the leptin gene was amplified. PCR products were digested with Hinf I restriction enzymes and was separated and visualized on the agarose gels. From possible three genotypes (TT, TC, and CC), only two genotypes TT and CC were observed in 14 studied domestic and wild populations with the genotype frequency of 95% and 5% respectively. The number of observed alleles, number of effective alleles, Nei’s Index and Shanon’s Index were 2, 1.10, 0.10 and 0.20 respectively. The studied populations were not found to be in HardyWeinberg equilibrium. Our investigation demonstrated that TT genotype and T allele had a very high frequency (0.95) in studied goats. Hence, it can be concluded that this finding can provide the basis for selection when considering evolution and differentiation among breeds, however, further studies should be carried out on a larger population of different domestic and wild breeds to verify the final conclusions

Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction

Background—Current guidelines only recommend the use of an implantable cardioverter defibrillator (ICD) in patients with dilated cardiomyopathy (DCM) for the primary prevention of sudden cardiac death (SCD) in those with a left ventricular ejection fraction (LVEF)35%. Patients with a LVEF>35% also have low competing risks of death from non-sudden causes. Therefore, those at high-risk of SCD may gain longevity from successful ICD therapy. We investigated whether late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) identified patients with DCM without severe LV systolic dysfunction at high-risk of SCD. Methods—We prospectively investigated the association between mid-wall late gadolinium enhancement (LGE) and the pre-specified primary composite outcome of SCD or aborted SCD amongst consecutive referrals with DCM and a LVEF≥40% to our center between January 2000 and December 2011, who did not have a pre-existing indication for ICD implantation. Results—Of 399 patients (145 women, median age 50 years, median LVEF 50%, 25.3% with LGE) followed for a median of 4.6 years, 18 of 101 (17.8%) patients with LGE reached the pre-specified end-point, compared to 7 of 298 (2.3%) without (HR 9.2; 95% CI 3.9-21.8; p5% compared to those without LGE were 10.6 (95%CI 3.9-29.4), 4.9 (95% CI 1.3-18.9) and 11.8 (95% CI 4.3-32.3) respectively. Conclusions—Mid-wall LGE identifies a group of patients with DCM and LVEF≥40% at increased risk of SCD and low-risk of non-sudden death who may benefit from ICD implantation